The uraemic toxin phenylacetic acid impairs macrophage function

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3485-3493

  Schmidt, Sven ^a   Westhoff, Timm H ^a   Krauser, Philipp ^a   Ignatius, Ralf ^a   Jankowski, Joachim ^a   Jankowski, Vera ^a   Zidek, Walter ^a   Van Der Giet, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

iNOS; Macrophage function; Phenylacetic acid; Uraemic toxin

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRITE; PHENYLACETIC ACID; UREMIC TOXIN;

ADULT; ANIMAL CELL; ARTICLE; CELL STIMULATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOREGULATION; INTRACELLULAR KILLING; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; SECOND MESSENGER; SIGNAL TRANSDUCTION; UREMIA; WESTERN BLOTTING;

ADULT; ANIMALS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MICE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PHENYLACETATES; PHOSPHORYLATION; PLASMA; RNA, MESSENGER;

EID: 54149094147     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn266     Document Type: Article

References (29)

1. Vanholder R, Van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20: 477-480
2. Chavers BM, Solid CA, Gilbertson DT et al. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 2007; 18: 952-959
3. Allon M, Depner TA, Radeva M et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 2003; 14: 1863-1870
4. Vanholder V, Hoenich N, Ringoir S. Morbidity and mortality of central venous catheter hemodialysis: a review of 10 years' experience. Nephron 1987; 47: 274-279
5. Dhondt AW, Vanholder RC, Waterloos MA et al. Leukocyte CD14 and CD45 expression during hemodialysis: polysulfone versus cuprophane. Nephron 1996; 74: 342-348
6. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773
7. Churchill DN, Taylor DW, Cook RJ et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-234
8. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-350
9. Chan J, Xing Y, Magliozzo RS et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-1122
10. Jankowski J, Van Der Giet M, Jankowski V et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 2003; 112: 256-264
11. Kim SG, Kim HJ, Choi SH et al. Inhibition of lipopolysaccharide- induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver 2000; 20: 319-329
12. Vazquez-Torres A, Jones-Carson J, Mastroeni P et al. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis: I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 2000; 192: 227-236
13. Garcia-Leoni ME, Martin-Scapa C, Rodeno P et al. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990; 9: 283-285
14. Touraine JL, Touraine F, Revillard JP et al. T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron 1975; 14: 195-208
15. Diefenbach A, Schindler H, Donhauser N et al. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998; 8: 77-87
16. MacMicking JD, North RJ, LaCourse R et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94: 5243-5248
17. Chan J, Tanaka K, Carroll D et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63: 736-740
18. Adams LB, Dinauer MC, Morgenstern DE et al. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 1997; 78: 237-246
19. Tsai WC, Strieter RM, Zisman DA et al. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 1997; 65: 1870-1875
20. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004; 2: 820-832
21. Bertholet S, Tzeng E, Felley-Bosco E et al. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 1999; 65: 50-58
22. Chan ED, Riches DW. IFN-gamma+LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 2001; 280: C441-C450
23. Kim YM, Lee BS, Yi KY et al. Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW264.7 macrophages. Biochem Biophys Res Commun 1997; 236: 655-660
24. Chan ED, Chan J, Schluger NW. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Respir Cell Mol Biol 2001; 25: 606-612
25. Muniz-Junqueira MI, Braga Lopes C, Magalhaes CA et al. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Life Sci 2005; 77: 3141-3155
26. Haag-Weber M, Cohen G, Horl WH. Clinical significance of granulocyte-inhibiting proteins. Nephrol Dial Transplant 2000; 15(Suppl 1): 15-16
27. Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000; 173: 17-26
28. Pahan K, Sheikh FG, Namboodiri AM et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997; 100: 2671-2679
29. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501